OSR Holdings, Inc. (NASDAQ:OSRH) Short Interest Up 101.1% in January

by · The Cerbat Gem

OSR Holdings, Inc. (NASDAQ:OSRH – Get Free Report) was the recipient of a significant growth in short interest in the month of January. As of January 15th, there was short interest totaling 1,094,583 shares, a growth of 101.1% from the December 31st total of 544,307 shares. Based on an average trading volume of 4,985,615 shares, the days-to-cover ratio is presently 0.2 days. Currently, 10.8% of the company’s shares are sold short. Currently, 10.8% of the company’s shares are sold short. Based on an average trading volume of 4,985,615 shares, the days-to-cover ratio is presently 0.2 days.

OSR Stock Performance

NASDAQ:OSRH traded down $0.06 during mid-day trading on Friday, hitting $0.58. 537,861 shares of the stock traded hands, compared to its average volume of 3,151,732. The firm’s 50 day moving average is $0.66 and its two-hundred day moving average is $0.67. OSR has a 52 week low of $0.45 and a 52 week high of $11.84.

OSR (NASDAQ:OSRH – Get Free Report) last released its quarterly earnings data on Wednesday, November 12th. The company reported ($0.10) EPS for the quarter. The business had revenue of $0.63 million during the quarter.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on OSRH shares. Weiss Ratings restated a “sell (e+)” rating on shares of OSR in a report on Monday, December 29th. Wall Street Zen raised OSR to a “sell” rating in a report on Saturday, October 18th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, OSR currently has an average rating of “Sell”.

Check Out Our Latest Stock Analysis on OSR

Institutional Investors Weigh In On OSR

A hedge fund recently bought a new stake in OSR stock. Susquehanna International Group LLP acquired a new stake in OSR Holdings, Inc. (NASDAQ:OSRH – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 79,807 shares of the company’s stock, valued at approximately $43,000. Susquehanna International Group LLP owned 0.37% of OSR at the end of the most recent quarter. 55.30% of the stock is currently owned by hedge funds and other institutional investors.

About OSR

(Get Free Report)

OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D “platform technologies” versus “assets only” companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials.

See Also